The NIH has selected OMRF to lead a $58.5 million public-private partnership aimed at developing more effective treatments for autoimmune diseases.
Judith James
OMRF co-leading national extra dose Covid-19 vaccine trial in people with autoimmune disease
OMRF was chosen because it is one of just 10 designated Autoimmunity Centers of Excellence in the U.S.
Eureka Moments
The new millennium began with a bang at OMRF, as Dr. Jordan Tang, above, and his research team identified and cloned the enzyme believed to cause Alzheimer’s disease. Soon after, the OMRF scientists designed an inhibitor that stopped the enzyme in its tracks. The discoveries led to the development of an experimental drug acquired by […]
Back to the Bench
Scientists adapt to a changed research environment.
OMRF looks to digestive system for origins of osteoarthritis
The NIH has awarded OMRF scientist Matlock Jeffries $874,000 to launch an innovative study of the origin and progression of OA.
A Battle That Never Ends
Renita Lewis fights lupus, which takes an outsized toll on African Americans.
